Pharma BD Deal Intelligence
A cheap, well-integrated bolt-on that fed Inverness's early growth engine — small piece of a much bigger (and messier) diagnostics roll-up story that ended with Abbott buying the whole platform back in 2017.
Full analysis, sources & comparables →Inverness invests $92.5 million in Abbott rapid diagnostic lines, picking up Fact Plus pregnancy plus TestPack/Signify professional rapid tests for strep,…
Fourth major acquisition by Inverness within 12 months; Covington arranged a $135 million senior debt facility to fund the cash portion, with management citing…
Source summaries from our enrichment pipeline; follow links for originals.
All 4 sources with sentiment breakdown →
Closed September 30, 2003. $55M cash + 1.55M shares = ~$92.5M. Pregnancy and illicit drug test divisions. Foundational to Inverness/Alere. Sources: Inverness 8-K SEC, prior 10-K filings.
A cheap, well-integrated bolt-on that fed Inverness's early growth engine — small piece of a much bigger (and messier) diagnostics roll-up story that ended with Abbott buying the whole platform back in 2017.
Assessment window: 15yr post-close.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Inverness Medical Innovations Inc. / Abbott Laboratories Rapid Diagnostics (pregnancy / drug-of-abuse lines) (this deal) | 2003 | $92M | 71 |
| Inverness Medical Innovations Inc. / Innogenetics Diagnostica y Terapeutica S.A. (IDT) | 2005 | $19M | 45 |
| Inverness Medical Innovations Inc. / Ischemia Technologies Inc. | 2004 | $22M | 33 |
| Inverness Medical Innovations Inc. / Thermo BioStar, Inc. | 2005 | $52M | 31 |
| Inverness Medical Innovations Inc. / Binax Inc. | 2004 | — | — |
| Eli Lilly and Company / Applied Molecular Evolution Inc. | 2003 | $400M | 88 |
| Takeda Pharmaceutical Company Ltd. / Millennium Pharmaceuticals | 2003 | $8.8B | 82 |